InsiderTrades

Form 4 for VRTX Vertex Pharmaceuticals

Accepted 2023-02-03 00:00:00 ET · period of report 2023-02-01 · accession 0001209191-23-006973 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
I 2023-02-03 2022-05-17 VRTX Sachdev Amit EVP, Chief Patient Off G - Gift $0.00 -1,672 11.1K -13% $0
M 2023-02-03 2023-02-01 VRTX Sachdev Amit EVP, Chief Patient Off A - Grant $0.00 +26.4K 79.8K +49% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-05-17 G D 1,672 $0.00 11,052 I Held in Trust — —
2 Common Common Stock 2023-02-01 A A 10,324 $0.00 63,676 D — — (F1) Represents earned performance shares with respect to a performance stock unit award granted on 02/05/2020 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/01/2023 and the shares will vest on 02/13/2023.
3 Common Common Stock 2023-02-01 A A 8,210 $0.00 71,886 D — — (F2) Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2022 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/01/2023 and the shares will vest in installments beginning on 02/24/2023.
4 Common Common Stock 2023-02-01 A A 7,866 $0.00 79,752 D — — (F3) Restricted stock unit award that vests in installments beginning on 02/10/2024.